Meridian Targets Magellan Biosciences

Lead poisoning has been a prominent news story this year, thanks to the tragic circumstances now playing out in Flint, Michigan. So it’s no surprise that Magellan Biosciences, Inc. and its subsidiary, Magellan Diagnostics, Inc., have been sold to Meridian Bioscience, Inc. (NASDAQ: VIVO) for $66 million. Majority owner Ampersand Capital Partners, together with Tekla Capital Management and Boston Community Venture Fund, made their exit from the business. Magellan has built a national reputation for point-of-care testing kits that measure levels of lead in the bloodstream. Its LeadCare® II, LeadCare Ultra and Plus systems are used by more than 6,500 physician offices and clinics in the... Read More »

Advent International Acquires ATI Physical Therapy

Private equity continues to invest in rehabilitation companies. The latest deal, the fifth of five announced in March 2016, is from Advent International, a Boston-based firm with more than $30 billion invested in 310 companies. For an undisclosed price, the firm took a majority interest in ATI Physical Therapy, a portfolio company of KRG Capital. ATI specializes in outpatient rehabilitation and adjacent healthcare services. It operates more than 500 clinics in 19 states, and served nearly 300,000 unique patients in 2015. Read More »

Biotechnology CROs Are Trading Again

Two contract research organizations (CROs) have changed hands in the past two weeks. On March 17, Hamburg, Germany-based IPM Biotech was acquired by BioAgilytix, a portfolio company of Riverside Partners, in Durham, North Carolina. As its name implies, IPM Biotech specializes in biotech research, specifically in large molecule bioanalysis in the area of immunogenicity. The transaction expands BioAgilytix’s global footprint with IPM’s newly planned GLP and GMB laboratory facility. Its services complement IPM’s rich immunogenicity, pharmacokinetics and pharmacodynamics expertise. Less than a week later, LakePharma, Inc., a CRO in Belmont, California, acquired Blue Sky... Read More »

Two For-Profit Hospital Systems Merge

Two hospital chains that changed hands only last year announced their merger on March 22. RegionalCare Health Partners Inc., based in Brentwood, Tennessee, and Capella Healthcare, Inc., located in nearby Franklin, will form RCCH Health Partners when the deal closes in the second quarter. The combined system will have 18 hospital campuses in 12 states with more than 13,000 employees, 2,000 affiliated physicians and $1.7 billion in revenue. Only last July, Capella Healthcare was sold by GTCR to Medical Properties Trust, Inc. (MPT) and Capella management for approximately $900 million. In November, Apollo Global Management (NYSE: APO) paid an undisclosed price for RegionalCare, which was then... Read More »

Sleep Services Goes to MedBridge Healthcare

Sleep disorders continue to spawn acquisitions. In February, ResMed Inc. (NYSE: RMD) paid $800 million for Brightree, a digital health company focused on post-acute segments that have a high prevalence of sleep-disordered breathing problems. This month, MedBridge Healthcare, a portfolio company of Vicente Capital Partners, paid an undisclosed price for Sleep Services of America, a wholly-owned subsidiary of the John Hopkins Health System. The Glen Burnie, Maryland-based company operates locations in Georgia, Maryland, New York, North Carolina and the District of Columbia, providing diagnosis, treatment and diagnostic studies for sleep disorders. The deal is a good fit for MedBridge,... Read More »

Complementary Specialty Pharmacies Merge

Apothecary by Design, a specialty pharmacy based in Portland, Maine, has acquired privately held Healy Pharmacy for an undisclosed price. The Warrenville, Illinois-based target focuses on infertility, gastroenterology, hepatitis, oncology, HIV, dermatology and rheumatoid arthritis. Both target and acquirer specialize in infertility treatment, serving complementary geographic markets with little overlap. This acquisition will blend each pharmacy’s unique areas of expertise, such as Healy’s strength in oncology and ABD’s experience in infectious and inflammatory diseases. Apothecary by Design was acquired in August 2015 by BelHealth Investment Partners for an undisclosed... Read More »